Google is rolling out a new image-generating AI model, Imagen 4, that the company claims delivers higher-quality results than ...

A University of Cambridge study found people's ability to think in abstract ways was boosted by admiring art. The results were measured after a group of 187 people were encouraged to judge the ...

Weeks after the FDA lifted a more than two-year-long hold, the biotech has set out plans to reduce its workforce by 20% and prioritize its clinical Duchenne muscular dystrophy (DMD) candidates and ...

Stealth CEO Reenie McCarthy, in the company’s statement, also said that the agency has been working with the biotech to “progress its review” and recently began labeling discussions. However, the ...

The Department of Health and Human Services (HHS) has lifted a stop work order on Vaxart’s phase 2b trial testing out an investigational COVID-19 vaccine pill, with the biotech resuming plans to ...

Mer­ck KGaA said Mon­day it has inked a “de­fin­i­tive agree­ment” to ac­quire Pfiz­er spin­out Spring­Works Ther­a­peu­tics for an eq­ui­ty val­ue of around $3.9 bil­lion ...

Investing.com -- HSBC downgraded several major biotech names this week, citing macroeconomic sensitivities, tariff risks, and growing pressure from regulatory changes. Most notably, the bank ...

German drug company Merck KGaA said Monday it has struck a deal to buy U.S. biotech firm SpringWorks Therapeutics for around $3.9 billion, expanding its portfolio of rare disease and cancer ...

IO Biotech's co-founder presented advancements in cancer vaccines at the 2025 AACR Annual Meeting, highlighting innovative therapeutic strategies. IO Biotech, a clinical-stage biopharmaceutical ...

The CRISPR biotech is now shelving the autoimmune program and slashing staff in order to focus its resources and its finances on the two lead cancer programs, whose data readouts have been delayed ...